IL6 and graft versus host disease: Taken together, the previous studies reviewed above have demonstrated IL-6 receptor ligation initiates downstream JAK/STAT signaling, and both IL-6 inhibition but especially JAK1/2 inhibition can be used in the treatment of GVHD.